Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

CombatSepsis

Reference number
Coordinator Lunds universitet - Lunds universitet Inst f kliniska vetenskaper
Funding from Vinnova SEK 1 300 000
Project duration December 2019 - November 2021
Status Completed
Venture 2017-01599-en

Important results from the project

Our objective were to create 1. An increased awareness of sepsis, 2. A survey of sepsis incidence and antibiotic resistance, 3. Improved follow-up of sepsis survivors. We have together with the Sepsis Foundation, among other things. conducted a national sepsis campaign that reached about 2 million Swedes. Together with European Sepsis Alliance, we conducted a pilot study that will form the basis of the large European sepsis incidence study EUSEP. We have started a follow-up clinic for sepsis patients that runs in parallel with the work with postCOVID.

Expected long term effects

We have followed up with another awareness campaign which shows that sepsis awareness has increased from 21% in 2015 to 49% in 2021! Our results show 1. that 5% of all hospital admissions are caused by sepsis 2. that the incidence of sepsis in Sweden is even higher than we previously thought 3. Att Covid increased the number of hospital admissions from 55 to 7% and 4. That antibiotic-resistant bacteria are uncommon as a cause of sepsis (only 1.8%) which is important information for both treatment guidelines and research strategy We have started the first follow-up clinic for sepsis patients.

Approach and implementation

Our successful results will have a major impact on sepsis care and research. An increased awareness among the population can save lives, a careful mapping of the incidence and connection to AMR and COVID is important partly because we can show that AMR does not cause sepsis and thus serious disease to a large extent in Sweden today but sepsis affects more than cancer despite that we have effective antibiotics. This knowledge should lead to research resources being invested in improved diagnostics and improved alternative treatment for sepsis. PostCOVID is a form of postSepsis.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 21 January 2022

Reference number 2019-05392